Context There is evidence that heart rate variability (HRV) is reduced in major depressive disorder (MDD), although there is debate about whether this effect is caused by medication or the disorder per se. MDD is associated with a two to fourfold increase in the risk of cardiac mortality, and HRV is a robust predictor of cardiac mortality; determining a direct link between HRV and not only MDD, but common comorbid anxiety disorders, will point to psychiatric indicators for cardiovascular risk reduction. Objective To determine in physically healthy, unmedicated patients whether (1) HRV is reduced in MDD relative to controls, and (2) HRV reductions are driven by MDD alone, comorbid generalized anxiety disorder (GAD, characterized by anxious anticipation), or comorbid panic and posttraumatic stress disorders (PD/PTSD, characterized by anxious arousal). Design, Setting, and Patients A case-control study in 2006 and 2007 on 73 MDD patients, including 24 without anxiety comorbidity, 24 with GAD, and 14 with PD/PTSD. Seventy-three MDD and 94 healthy age- and sex-matched control participants were recruited from the general community. Participants had no history of drug addiction, alcoholism, brain injury, loss of consciousness, stroke, neurological disorder, or serious medical conditions. There were no significant differences between the four groups in age, gender, BMI, or alcohol use. Main Outcome Measures HRV was calculated from electrocardiography under a standardized short-term resting state condition. Results HRV was reduced in MDD relative to controls, an effect associated with a medium effect size. MDD participants with comorbid generalized anxiety disorder displayed the greatest reductions in HRV relative to controls, an effect associated with a large effect size. Conclusions Unmedicated, physically healthy MDD patients with and without comorbid anxiety had reduced HRV. Those with comorbid GAD showed the greatest reductions. Implications for cardiovascular risk reduction strategies in otherwise healthy patients with psychiatric illness are discussed.
References
[1]
Ziegelstein RC (2001) Depression in patients recovering from a myocardial infarction. pp. 1621–1627. JAMA: The Journal of the American Medical Association. Vol. 286.
[2]
Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27: 2763–2774. doi:10.1093/eurheartj/ehl338.
[3]
Barth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66: 802–813. doi:10.1097/01.psy.0000146332.53619.b2.
[4]
Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, et al. (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58: 221–227.
[5]
Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, et al. (2009) Depression and Risk of Sudden Cardiac Death and Coronary Heart Disease in Women. J Am Coll Cardiol 53: 950–958. doi:10.1016/j.jacc.2008.10.060.
[6]
Taylor CB (2010) Depression, heart rate related variables and cardiovascular disease. Int J Psychophysiol 78: 80–88. doi:10.1016/j.ijpsycho.2010.04.006.
[7]
Carney RM, Freedland KE (2009) Depression and heart rate variability in patients with coronary heart disease. Cleve Clin J Med 76: S13–S17. doi:10.3949/ccjm.76.s2.03.
[8]
Porges SW (2011) The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-regulation. 1st ed. New York: W. W. Norton & Company.
[9]
Thayer JF, Hansen AL, Saus-Rose E, Johnsen BH (2009) Heart rate variability, prefrontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health. Ann Behav Med 37: 141–153. doi:10.1007/s12160-009-9101-z.
[10]
Thayer JF, Lane RD (2000) A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord 61: 201–216.
[11]
Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, et al. (2000) Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 102: 1239–1244.
[12]
Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, et al. (2010) Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 67: 1067–1074. doi:10.1016/j.biopsych.2009.12.012.
[13]
Licht CMM, de Geus EJC, van Dyck R, Penninx BWJH (2009) Association between anxiety disorders and heart rate variability in The Netherlands Study of Depression and Anxiety (NESDA). Psychosom Med 71: 508–518. doi:10.1097/PSY.0b013e3181a292a6.
[14]
Licht CMM, de Geus EJC, Zitman FG, Hoogendijk WJG, van Dyck R, et al. (2008) Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 65: 1358–1367. doi:10.1001/archpsyc.65.12.1358.
[15]
Rottenberg J (2007) Cardiac vagal control in depression: a critical analysis. Biol Psychol 74: 200–211. doi:10.1016/j.biopsycho.2005.08.010.
[16]
Kemp A (2011) Depression, antidepressant treatment and the cardiovascular system. Acta Neuropsychiatrica 23: 82–83. doi:DOI 10.1111/j.1601-5215.2011.00535.x.
[17]
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617–627. doi:10.1001/archpsyc.62.6.617.
[18]
Friedman BH (2007) An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biol Psychol 74: 185–199. doi:10.1016/j.biopsycho.2005.08.009.
[19]
Vogelzangs N, Seldenrijk A, Beekman ATF, van Hout HPJ, de Jonge P, et al. (2010) Cardiovascular disease in persons with depressive and anxiety disorders. J Affect Disord 125: 241–248. doi:10.1016/j.jad.2010.02.112.
[20]
Thayer JF, Friedman BH, Borkovec TD (1996) Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatry 39: 255–266. doi:10.1016/0006-3223(95)00136-0.
[21]
Gordon E (2003) Integrative Neuroscience. Neuropschopharmacology 28: S2–S8. doi:10.1038/sj.npp.1300136.
[22]
Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, et al. (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22.
[23]
Williams JB (1988) A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 45: 742–747.
[24]
Hickie I, Davenport T, Hadzi-Pavlovic D, Koschera A, Naismith S, et al. (2001) Development of a simple screening tool for common mental disorders in general practice. Med J Aust 175: S10–7.
[25]
Wilhelm KA, Finch AW, Davenport TA, Hickie IB (2008) What can alert the general practitioner to people whose common mental health problems are unrecognised? Med J Aust 188: 114.
[26]
Lovibond S, Lovibond P (1995) Manual for the depression, anxiety, stress scales. Psychology Foundation of Australia.
[27]
Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP (1998) Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychological Assessment 10: 176.
[28]
Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, et al. (2000) Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 102: 1239–1244.
[29]
Carnethon MR, Liao D, Evans GW, Cascio WE, Chambless LE, et al. (2002) Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality? The Atherosclerosis Risk in Communities Study. Am J Epidemiol 155: 48–56.
[30]
van Zyl LT, Hasegawa T, Nagata K (2008) Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. BioPsychoSocial Med 2: 12. doi:10.1186/1751-0759-2-12.
[31]
Serrador JM, Finlayson HC, Hughson RL (1999) Physical activity is a major contributor to the ultra low frequency components of heart rate variability. Heart 82: e9.
[32]
Tompkins WJ (1993) Biomedical digital signal processing: C-language examples and laboratory experiments for the IBM PC. Prentice Hall.
[33]
Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS (2006) Heart rate variability: a review. Medical & biological engineering & computing 44: 1031–1051. doi:10.1007/s11517-006-0119-0.
[34]
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 158: 1789–1795.
[35]
Kemp AH, Quintana DS, Malhi GS (2011) Effects of serotonin reuptake inhibitors on heart rate variability: methodological issues, medical comorbidity, and clinical relevance. Biol Psychiatry 69: e25––6; author reply e27–8. doi:10.1016/j.biopsych.2010.10.035.
[36]
Kemp AH, Quintana DS, Gray MA (2010) s Heart Rate Variability Reduced in Depression Without Cardiovascular Disease. BPS 1–2. doi:10.1016/j.biopsych.2010.07.030.
[37]
Licht CMM, Penninx BW, de Geus EJC (2011) To include or not to include? A response to the meta-analysis of heart rate variability and depression. Biol Psychiatry 69: e1; author reply e3–4. doi:10.1016/j.biopsych.2010.06.034.
[38]
Licht CMM, Penninx BWJH, Geus EJC de (2011) Reply to: Effects of Serotonin Reuptake Inhibitors on Heart Rate Variability: Methodological Issues, Medical Comorbidity, and Clinical Relevance. BPS 1–2. doi:10.1016/j.biopsych.2010.12.039.
[39]
Mogg K, Bradley BP (2005) Attentional Bias in Generalized Anxiety Disorder Versus Depressive Disorder. Cogn Ther Res 29: 29–45. doi:10.1007/s10608-005-1646-y.
[40]
Kop WJ, Stein PK, Tracy RP, Barzilay JI, Schulz R, et al. (2010) Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 72: 626–635. doi:10.1097/PSY.0b013e3181eadd2b.
[41]
Pizzi C, Manzoli L, Mancini S, Bedetti G, Fontana F, et al. (2010) Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 212: 292–298. doi:10.1016/j.atherosclerosis.2010.04.038.
[42]
Anuurad E, Enkhmaa B, Gungor Z, Zhang W, Tracy RP, et al. (2011) Age as a Modulator of Inflammatory Cardiovascular Risk Factors. Arteriosclerosis, Thrombosis, and Vascular Biology 31: 2151–2156. doi:10.1161/ATVBAHA.111.232348.
[43]
Thayer JF, Yamamoto SS, Brosschot JF (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141: 122–131. doi:10.1016/j.ijcard.2009.09.543.
[44]
Thayer JF (2009) Vagal tone and the inflammatory reflex. Cleve Clin J Med 76: Suppl 2S23–6. doi:10.3949/ccjm.76.s2.05.
